Heartflow Inc (HTFL): Price to Sales

Symbol and logo of brand HeartFlow Corp (HTFL)

Heartflow Inc is implementing AI for non-invasive blood flow diagnostics based on CT scans, expanding insurance coverage. The price-to-sales ratio clearly demonstrates market expectations, where 24.50 captures the current value of the indicator. Leading data scientists working with unique datasets are building the company's technology stack. Management is currently focusing on scaling commercial processes to validate the clinical value of its digital platforms.

HTFL heartflow.com: Market Cap to Revenue in the range 08/09/2025 - 11/13/2026

Metric breakdowns and analytics for HeartFlow Corp (HTFL)

- current price and projected stock value:
Price Chart HeartFlow, Inc.|HTFL - Price Target Chart
- stock exchange capitalization data:
Market Value HeartFlow Corp|HTFL - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Accounting Value per Share HeartFlow|HTFL - Company Net Assets|Market Value to Book Value heartflow.com|HTFL - Company Total Assets
- business debt structure and liquidity details:
Total Debt to Capital Coefficient Heartflow Inc|HTFL - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio HeartFlow Medical|HTFL - Company Aggregate Debts|Debt to Book Value HeartFlow Corp|HTFL - Company Long-Term Debts|Company Short-Term Loans and Borrowings HeartFlow|Intermediate Liquidity Ratio heartflow.com
- business earnings and investment ratios data:
HTFL - Net Profit|Forward Earnings Heartflow Inc|HTFL - Price to Earnings Ratio|Future Price to Earnings HeartFlow|HTFL - PEG Multiple|Business Value to Operating Income Before Depreciation HeartFlow Corp|HTFL - Operating profit EBITDA|Net earnings per one share for the last twelve months HeartFlow|HTFL - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth heartflow.com|HTFL - Earnings per share growth in current year|Expected earnings per share trend next year Heartflow Inc
- sales revenue and business income indicators:
HTFL - Company Sales|Company Projected Revenue Volume HeartFlow Corp|HTFL - P/S Multiple|Forward Price to Sales HeartFlow Corp
General company analysis:HTFL (heartflow.com)
Core merchandise of heartflow.com

For Heartflow Inc (HTFL), which develops high-tech cardiology software with no direct environmental impact, revenue serves as the key driver of capitalization. By analyzing the price-to-sales ratio, an investor compares the market share price with actual business earnings to determine the asset's degree of overvaluation and distinguish genuine growth from speculative momentum, based on the price action reflected in this chart.

Competing companies

Price-to-Revenue Ratio REGN (regeneron.com)|Price-to-Revenue Ratio iRhythm IRTC|Lantheus Holdings (LNTH) - Price to Sales|MLYS: Market Cap to Revenue|Kestra Medical Corp (KMTS) - Market Cap to Revenue|ESPR (Esperion Therapeutics) - Market Cap to Revenue|amarincorp.com - Market Capitalization-to-Revenue Ratio|AVR (Anteris) - P/S Multiple|Tenaya Therapeutics Inc (TNYA) - Price-to-Revenue Coefficient|Price-to-Revenue Ratio CVRx, Inc (CVRX)|Milestone Pharmaceuticals Inc - Market Cap to Revenue Ratio|P/S Multiple CRDL (Cardiol Therapeutics Inc.)|BEAT - Market Cap to Revenue|Tenax Therapeutics, Inc. - P/S Multiple|Market Capitalization-to-Revenue Ratio ADGM (Adagio Medical Holdings, Inc.)|BCDA (BioCardia, Inc) - Market Cap to Revenue|VTAK: Market Cap to Sales Volume|ABIO (ARCA Biopharma Inc) - P/S Multiple|Acasti - Price-to-Sales Ratio|Price-to-Revenue Ratio Aerovate Therapeutics, Inc. (AVTE)|Price-to-Revenue Ratio VERV (vervetx.com)|P/S Multiple WINT (Windtree Therapeutics, Inc.)